Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu +10 more
wiley +1 more source
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam +3 more
wiley +1 more source
Stepwise Management of Refractory Ventricular Arrhythmias in Desmoplakin Cardiomyopathy: A Case Report. [PDF]
Ibitamuno G +4 more
europepmc +1 more source
Cardiopulmonary exercise testing is safe in hypertrophic cardiomyopathy - Incidence and outcomes of sustained ventricular arrhythmias in a large referral cohort. [PDF]
Csecs I +6 more
europepmc +1 more source
Developmental Hypoxia Increases Susceptibility to Cardiac Ventricular Arrhythmias in Adult Offspring
Lock MC +13 more
europepmc +1 more source
Echocardiographic Predictors of Ventricular Arrhythmias Post-Automatic Implantable Cardioverter-Defibrillator Implantation. [PDF]
Harapoz M +4 more
europepmc +1 more source
Conduction System Pacing With Defibrillator Therapy in a Patient With Heart Failure and Ventricular Arrhythmias After Mitral Valve Replacement. [PDF]
Szulik M +8 more
europepmc +1 more source
Controlling Nutritional Status score as a predictor of ventricular arrhythmias in patients with advanced heart failure. [PDF]
Ono Y +11 more
europepmc +1 more source

